您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。 [香港联交所&香港证监会]:明智科技股份有限公司招股书申请版本 - 发现报告

明智科技股份有限公司招股书申请版本

报告封面

Application Proof of WiseTek Med Ltd. (the “Company”)(Incorporated in the Cayman Islands with limited liability) WARNING The publication of this Application Proof is required by The Stock Exchange of Hong Kong Limited (the“Exchange”) and the Securities and Futures Commission (the “Commission”) solely for the purpose of providinginformation to the public in Hong Kong. This Application Proof is in draft form. The information contained in it is incomplete and is subject to changewhich can be material. By viewing this document, you acknowledge, accept and agree with the Company, its solesponsor, overall coordinator, advisers or members of the underwriting syndicate that: (a)this document is only for the purpose of providing information about the Company to the public in HongKong and not for any other purposes. No investment decision should be based on the informationcontained in this document;(b)the publication of this document or supplemental, revised or replacement pages on the Exchange’s websitedoes not give rise to any obligation of the Company, its sole sponsor, overall coordinator, advisers ormembers of the underwriting syndicate to proceed with an offering in Hong Kong or any otherjurisdiction. There is no assurance that the Company will proceed with the listing;(c)the contents of this document or supplemental, revised or replacement pages may or may not be replicatedin full or in part in the actual final listing document;(d)the Application Proof is not the final listing document and may be updated or revised by the Companyfrom time to time in accordance with the Rules Governing the Listing of Securities on The Stock Exchangeof Hong Kong Limited;(e)thisdocument does not constitute a prospectus,offering circular,notice,circular,brochure oradvertisement offering to sell any securities to the public in any jurisdiction, nor is it an invitation to thepublic to make offers to subscribe for or purchase any securities, nor is it calculated to invite offers by thepublic to subscribe for or purchase any securities;(f)this document must not be regarded as an inducement to subscribe for or purchase any securities, and nosuch inducement is intended;(g)neither the Company nor any of its affiliates, advisers or underwriters is offering, or is soliciting offers tobuy, any securities in any jurisdiction through the publication of this document;(h)no application for the securities mentioned in this document should be made by any person nor wouldsuch application be accepted;(i)the Company has not and will not register the securities referred to in this document under the UnitedStates Securities Act of 1933, as amended, or any state securities laws of the United States;(j)as there may be legal restrictions on the publication of this document or dissemination of any informationcontained in this document, you agree to inform yourself about and observe any such restrictionsapplicable to you; and(k)the application to which this document relates has not been approved for listing and the Exchange and theCommission may accept, return or reject the application for the subject public offering and/or listing. If an offer or an invitation is made to the public in Hong Kong in due course, prospective investors are remindedto make their investment decisions solely based on the Company’s prospectus registered with the Registrar ofCompanies in Hong Kong, copies of which will be published to the public during the offer period. IMPORTANT If you are in any doubt about any of the contents of this document, you should obtain independent professional advice. WiseTek Med Ltd. (Incorporated in the Cayman Islands with limited liability) Number of[REDACTED]under the[REDACTED]:[REDACTED]Shares (subject to the[REDACTED])Number of[REDACTED]:[REDACTED]Shares (subject to[REDACTED])Number of[REDACTED]:[REDACTED]Shares (subject to[REDACTED]and the[REDACTED])Maximum[REDACTED]:HK$[REDACTED]per[REDACTED],plus brokerage of 1.0%, SFCtransaction levy of 0.0027%, StockExchange trading fee of 0.00565% andAFRC transaction levy of 0.00015%(payable in full on[REDACTED]inHong Kong dollars and subject torefund)Nominal value:US$0.00005 per Share[REDACTED]:[REDACTED] Sole Sponsor,[REDACTED] Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited and Hong Kong Securities Clearing Company Limited takeno responsibility for the contents of this document, make no representation as to its accuracy or completeness and expressly disclaim any liabilitywhatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this document. A copy of this document, having attached thereto the documents specified in “Documents Delivered to the Registrar of Companies and Available onDisplay — Documents Delivered to the Registrar of Companies and Available on Display” in Appendix V, has been registered by the Registrar ofCompanies in Hong Kong as required by section 342C of the Companies (Winding Up and Misce